International variations in central nervous system incidence in children and adolescents
International variations in central nervous system incidence in children and adolescents
复制标题
儿童和青少年中枢神经系统发病率的国际差异
DOI：
10.1093/jjco/hyac053
复制
发表时间：
2022
期刊：
影响因子：
2.4
通讯作者：
L. and T. Matsuda
中科院分区：
文献类型：
--
作者：
Gatellier;L. and T. Matsuda
为了比较日本和其他国家儿童青少年中枢神经系统（CNS）和颅内、椎管内杂项肿瘤的亚型分布，我们从国际儿童癌症发病率系列（IICC-3）第三卷中提取了儿童青少年癌症发病率的信息(1)。IICC-3报告了从全球癌症登记处（区域或国家）收集的儿童和青少年癌症的数量或发病率。我们分析了亚洲4个国家（日本、中国、韩国和泰国）、非洲2个国家（埃及和乌干达）、美洲4个国家（北美：美国和加拿大、拉丁和加勒比地区：巴西和哥伦比亚）、欧洲3个国家（英国、法国和德国）和大洋洲2个国家（澳大利亚和新西兰）的中枢神经系统和其他颅内和椎管内肿瘤的发病率。来自大韩民国、美国、英国、澳大利亚和新西兰的信息是在国家一级获得的，来自其他国家的信息来自一个或多个区域癌症登记处。要收集的发病率年份因国家而异，但范围为1990年至2014年，最短为12年（埃及：1999-2010年，英国：2000-2011年），最长为24年（日本和中国：均为1990 - 2013年）。在这项研究中，我们比较了这些国家儿童（0-14岁）和青少年（15-19岁）亚型的发病率和比例分布。国家特定年龄标准化中枢神经系统和其他颅内和椎管内肿瘤的发病率在儿童（0-14岁）中为每100万人年3.4至39.8例，在青少年（15-19岁）中为每100万人年2.2至35.7例。对于儿童，欧洲和北美的发病率较高（从英国的30.8到美国的39.8），而亚洲和非洲国家的发病率往往较低，特别是在乌干达，发病率为每100万人年3.4。青少年的发病率始终低于儿童，并且在各国之间遵循相同的模式。图1显示了各国0-14岁儿童中枢神经系统及颅内、椎管内杂项肿瘤亚型的比例分布。最常见的亚型是星形细胞瘤（比例从13.0%到13.0%不等）
In order to compare the subtype distribution of central nervous system (CNS) and miscellaneous intracranial and intraspinal neoplasms in children and adolescents between Japan and other countries, we extracted information on cancer incidence in children and adolescents from the third volume of the International Incidence of Childhood Cancer series (IICC-3)(1). The IICC-3 reports the number or incidence rates of cancers occurring in childhood and adolescence, collected from cancer registries (regional or national) worldwide. We analyzed CNS and miscellaneous intracranial and intraspinal neoplasms incidence in four countries in Asia (Japan, China, the Republic of Korea and Thailand), two countries in Africa (Egypt and Uganda), four countries in the Americas (North: the USA and Canada, Latin and Caribbean: Brazil and Colombia), three countries in Europe (the UK, France and Germany) and two countries in Oceania (Australia and New Zealand). Information from the Republic of Korea, USA, UK, Australia and New Zealand was obtained at the national level, and those from the other countries were from one or multiple regional cancer registries. The years of incidence to be collected varied from country to country, but ranged from 1990 to 2014, with the shortest being 12 years (Egypt: 1999–2010, UK: 2000–2011) and the longest being 24 years (Japan and China: both 1990–2013). In this study, we compared the incidence and proportional distribution of subtype in children (0–14 years old) and adolescents (15–19 years old) between these countries.The country-specific age-standardized CNS and miscellaneous intracranial and intraspinal neoplasms incidence rates varied between 3.4 and 39.8 per 1 000 000 person-years in children (0–14 years old) and between 2.2 and 35.7 per 1 000 000 person-years in adolescents (15–19 years old). For children, higher rates were observed in Europe and North America (ranging from 30.8 in the UK to 39.8 in the USA), while rates in Asian and African countries tended to be lower, especially in Uganda with a rate of 3.4 per 1 000 000 person-years. Rates for adolescents were consistently lower than rates for children and followed the same pattern between countries. Figure 1 shows the proportional distribution of subtypes of CNS and miscellaneous intracranial and intraspinal neoplasms in children aged 0–14 years by country. The most frequently identified subtypes were astrocytomas (with proportions ranging from 13.0% in